Shared on 13 Nov 25
Fair value Increased 0.65%BAYN: Future Legal Outcomes And Sector Dynamics Will Determine Momentum
Analysts have raised Bayer's price target slightly from $28.53 to $28.71, reflecting steady profit margin improvements and updated industry positioning. This adjustment comes particularly in light of ongoing strategic shifts among major agribusiness peers.
Shared on 23 Apr 25
Fair value Increased 3.54%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Decreased 7.39%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 4.10%AnalystConsensusTarget has increased discount rate from 5.2% to 5.8%.
Shared on 02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 1.78%AnalystConsensusTarget has decreased revenue growth from 1.2% to 1.0%.
Shared on 19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 2.26%AnalystConsensusTarget has increased profit margin from 5.7% to 6.4% and decreased future PE multiple from 11.5x to 10.3x.